1
|
Xiao S, Yuan J, Lan H, Li Q, Cheng Y, Cao K, Zeng X. Investigation of clinical medicine undergraduates' recognition of narrative medicine. BMC Med Educ 2024; 24:321. [PMID: 38515120 PMCID: PMC10958904 DOI: 10.1186/s12909-024-05279-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/11/2023] [Accepted: 03/08/2024] [Indexed: 03/23/2024]
Abstract
BACKGROUND Narrative Medicine (NM), a contemporary medical concept proposed in the 21st century, emphasizes the use of narrative as a literary form in medicine. This study aims to explore the understanding about NM and willingness to learn NM among medical students in our hospital. METHODS A questionnaire survey was conducted among 130 students at Xiangya Medical College of Central South University. RESULTS The findings revealed that a small percentage of students (3.1%) were familiar with narrative medicine and its training methods. Knowledge about the treatment skills (77.7%) and core content (55.4%) of narrative medicine was limited among the students. Despite this, a majority (63.1%) expressed a lack of interest in further understanding and learning about narrative medicine. Surprisingly, the survey indicated that students possessed a high level of narrative literacy, even without formal training in narrative medicine. Additionally, over half of the surveyed students (61.5%) believed that narrative medicine could benefit their clinical practice. CONCLUSIONS This study serves as a preliminary basis for the future development of narrative medicine education in China. It highlights the need to prioritize medical humanities education and provide medical students with more opportunities to access information on narrative medicine. By doing so, we can strive to enhance the visibility and promote the integration of narrative medicine into medical humanities education in China.
Collapse
Affiliation(s)
- Songshu Xiao
- Department of Obstetrics and Gynecology, the Third Xiangya Hospital of Central South University, 138 Tongzipo Road, Yuelu District, 410013, Changsha, Hunan, People's Republic of China
| | - Jing Yuan
- Department of Obstetrics and Gynecology, the Third Xiangya Hospital of Central South University, 138 Tongzipo Road, Yuelu District, 410013, Changsha, Hunan, People's Republic of China
| | - Hua Lan
- Department of Obstetrics and Gynecology, the Third Xiangya Hospital of Central South University, 138 Tongzipo Road, Yuelu District, 410013, Changsha, Hunan, People's Republic of China
- Department of Obstetrics and Gynecology, Changsha Central Hospital of University of South China, Changsha, China
| | - Qiaofen Li
- Department of Obstetrics and Gynecology, the Third Xiangya Hospital of Central South University, 138 Tongzipo Road, Yuelu District, 410013, Changsha, Hunan, People's Republic of China
| | - Yan Cheng
- Department of Pharmacy, The Second Xiangya Hospital, Central South University, 410011, Changsha, China
| | - Ke Cao
- Department of Oncology, the Third Xiangya Hospital of Central South University, 138 Tongzipo Road, Yuelu District, 410013, Changsha, Hunan, People's Republic of China.
| | - Xiangyang Zeng
- Department of Obstetrics and Gynecology, the Third Xiangya Hospital of Central South University, 138 Tongzipo Road, Yuelu District, 410013, Changsha, Hunan, People's Republic of China.
| |
Collapse
|
2
|
王 明, 姬 家, 赖 金, 唐 鑫, 胡 浩, 王 起, 许 克, 徐 涛, 胡 浩. [Choice of medical treatment for renal colic: A survey of Chinese urologists]. Beijing Da Xue Xue Bao Yi Xue Ban 2023; 55:871-875. [PMID: 37807742 PMCID: PMC10560911] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 03/20/2023] [Indexed: 10/10/2023]
Abstract
OBJECTIVE To investigate the status quo of recognition and management of renal colic among urological surgeons in China. METHODS From November 2021 to March 2022, 725 urological surgeons in China were surveyed in the form of a questionnaire, including their province, hospital grade, professional title, the number of patients with renal colic treated per week, the preferred drugs and the cognition of the disease. This study was approved by the Medical Ethics Committee of Peking University People's Hospital, and all respondents completed informed consent online. RESULTS During November 2021 and March 2022, urological surgeons across China were surveyed in the form of a questionnaire, and the reliability and validity of the questionnaire were verified before the study was carried out. In the study, 720 valid questionnaires were collected (accounting for 99.31% of the total number), in which 42.4% of the doctors' preferred drugs were non-steroidal anti-inflammatory drugs (NSAIDs), and 40.0% of the doctors' preferred antispasmodic drugs. Opioids were the first choice of 11.0% of the physicians and other treatments were preferred by 6.6% of physicians. In addition, 61.1% of the doctors thought that the mechanism of renal colic was elevated prostaglandin, 32.2% thought it was ureteral spasm, 5.0% thought it was calculi irritation, and 1.7% thought the mechanism was unclear. The doctor of the cognition of the generation mechanism of renal colic pain had a significant influence on the preferred treatment option (χ2=54.399, P < 0.001) that the "elevated prostaglandins" doctor more often preferred NSAIDs than the doctor who thought cramps and ureter stones caused renal colic (51.6% vs. 28.0%, χ2=34.356, P < 0.001;51.6% vs. 19.4%, χ2=13.759, P < 0.001). In addition, hospital class, physician title, and the number of weekly consultations by physicians influenced the choice of medications for renal colic (P < 0.05), tertiary hospitals, middle and senior professional titles and weekly patients with renal colic > 8 cases generally preferred NSAIDs. CONCLUSION There are deficiencies in the cognition and drug treatment of renal colic among urological surgeons in China. The choice of the preferred drug was related to the doctor's cognition of the disease, the grade of the hospital, the doctor's professional title and the weekly treatment volume.
Collapse
Affiliation(s)
- 明瑞 王
- />北京大学人民医院泌尿外科, 北京 100044Department of Urology, Peking University People's Hospital, Beijng 100044, China
| | - 家祥 姬
- />北京大学人民医院泌尿外科, 北京 100044Department of Urology, Peking University People's Hospital, Beijng 100044, China
| | - 金惠 赖
- />北京大学人民医院泌尿外科, 北京 100044Department of Urology, Peking University People's Hospital, Beijng 100044, China
| | - 鑫伟 唐
- />北京大学人民医院泌尿外科, 北京 100044Department of Urology, Peking University People's Hospital, Beijng 100044, China
| | - 浩浦 胡
- />北京大学人民医院泌尿外科, 北京 100044Department of Urology, Peking University People's Hospital, Beijng 100044, China
| | - 起 王
- />北京大学人民医院泌尿外科, 北京 100044Department of Urology, Peking University People's Hospital, Beijng 100044, China
| | - 克新 许
- />北京大学人民医院泌尿外科, 北京 100044Department of Urology, Peking University People's Hospital, Beijng 100044, China
| | - 涛 徐
- />北京大学人民医院泌尿外科, 北京 100044Department of Urology, Peking University People's Hospital, Beijng 100044, China
| | - 浩 胡
- />北京大学人民医院泌尿外科, 北京 100044Department of Urology, Peking University People's Hospital, Beijng 100044, China
| |
Collapse
|
3
|
Shan J, Lv S, Chen L, Li T, Li J, Wang S, Zhang C. A cross-sectional study on Chinese oncology nurses' knowledge of bone health among cancer patients. Support Care Cancer 2023; 31:501. [PMID: 37526757 PMCID: PMC10393862 DOI: 10.1007/s00520-023-07966-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2023] [Accepted: 07/23/2023] [Indexed: 08/02/2023]
Abstract
OBJECTIVE To understand the knowledge status, obstacle factors, and management confidence of oncology nurses on the bone health of cancer patients, and in addition to provide reference for establishing bone health knowledge training system for oncology nurses and guiding them to manage bone health of cancer patients. METHODS A total of 602 nurses engaged in oncology nursing in 6 hospitals in Hebei Province were selected by cluster sampling, and an online anonymous survey was conducted by sending questionnaires to oncology nurses from the Hebei Cancer Prevention and Control Association. The questionnaire was developed by the study team. There are 4 parts, namely general information, nurses' role and job responsibilities, knowledge of skeletal-related events (SREs) and cancer treatment-induced bone loss (CTIBL), and understanding and confidence in bone health management, for a total of 33 questions. RESULTS Thirty-seven percent of oncology nurses received training on bone health and other related contents; 40.48% of oncology nurses used domestic and foreign guidelines when managing patients with bone metastases or CTIBL. Only approximately one-third of oncology nurses had confidence in managing the side effects of bone metastases and bone modification drugs and identifying patients at risk of CTIBL and fracture; only 33.04% of oncology nurses believed that weight-bearing exercise can prevent bone loss; less than 50% of oncology nurses believed that aromatase inhibitor therapy, ovarian suppression therapy, androgen deprivation therapy, and low body weight were risk factors for pathological fractures. The reasons that hindered oncology nurses from optimizing the management of patients with bone metastases and understanding the preventive measures and risk factors for bone loss mainly included lack of relevant knowledge training, lack of understanding of effective intervention measures, and lack of training and professionalism of specialized nurses, including insufficient development time and guidelines for clinical nursing practice. CONCLUSION Managers must continuously improve the training system of oncology nurses, enrich the content of training pertaining to bone health for cancer patients, formulate clinical nursing practice guidelines, and give oncology nurses more time for professional development.
Collapse
Affiliation(s)
- Jing Shan
- Department of Orthopedics, The Fourth Hospital of Hebei Medical University, Hebei Provincial Cancer Institute, No. 12, Jiankang Road, Chang'an District, Shijiazhuang, Hebei, China.
| | - Sumei Lv
- Department of Orthopedics, The Fourth Hospital of Hebei Medical University, Hebei Provincial Cancer Institute, No. 12, Jiankang Road, Chang'an District, Shijiazhuang, Hebei, China
| | - Lu Chen
- Nursing Department, The Fourth Hospital of Hebei Medical University, Hebei Provincial Cancer Institute, Shijiazhuang, Hebei, China
| | - Tianhua Li
- Department of Gynecological, The Fourth Hospital of Hebei Medical University, Hebei Provincial Cancer Institute, Shijiazhuang, Hebei, China
| | - Jingwen Li
- Department of Orthopedics, The Fourth Hospital of Hebei Medical University, Hebei Provincial Cancer Institute, No. 12, Jiankang Road, Chang'an District, Shijiazhuang, Hebei, China
| | - Shuangyan Wang
- Department of Orthopedics, The Fourth Hospital of Hebei Medical University, Hebei Provincial Cancer Institute, No. 12, Jiankang Road, Chang'an District, Shijiazhuang, Hebei, China
| | - Congcong Zhang
- Department of Orthopedics, The Fourth Hospital of Hebei Medical University, Hebei Provincial Cancer Institute, No. 12, Jiankang Road, Chang'an District, Shijiazhuang, Hebei, China
| |
Collapse
|
4
|
He N, Hao S, Feng G, Gao J, Kong FJ, Ren ZX, Xu MQ, Yang YQ. [Analysis of the factors influencing the elimination strategies with the current status of diagnosis and treatment of hepatitis C in hospital]. Zhonghua Gan Zang Bing Za Zhi 2021; 29:1053-1058. [PMID: 34933422 DOI: 10.3760/cma.j.cn501113-20210119-00034] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
Objective: To understand the current status of screening, diagnosis, and treatment and analyze the factors influencing micro-elimination strategy, so as to achieve hepatitis C elimination in hospital. Methods: Anti-HCV and HCV RNA test results of patients from October 2017 to September 2020 were retrospectively analyzed. Anti-HCV positive rates and factors influencing different genders, ages, places of residence and departments were analyzed. After comparing anti-HCV-positive patients with HCV RNA-positive patients with duplicate entries in "Name" and "Date of birth", the data were divided into three categories: anti-HCV positive without HCV RNA test, HCV RNA positive in single test, and HCV RNA positive many times in multiple tests. The above three types of patients were followed-up by telephone. According to the hospital follow-up results, current status of diagnosis and treatment and the factors influencing the micro-elimination strategy of hepatitis C were studied and analyzed. The comparison of data between groups were performed using χ(2) or χ(2) continuity-correction test. Results: Anti-HCV positive detection rate was 1.34% (899/66 866). The positive rate of male patients aged 40 and over residing in cities was significantly higher than female patients under 40 years old residing in rural areas, and the difference was statistically significant (χ(2) = 55.178, 264.11, 36, 351, P < 0.05). There were 90 (10.02%) and 809 cases (89.98%) in outpatient and inpatient departments, respectively, with no statistically significant difference between the two (χ(2) = 0.002, P > 0.05). The total number of anti-HCV positive cases were 196 in Gastroenterology (22.0%), 75 in Respiratory and Critical Care Medicine (8.3%), 74 in Neurology (8.2%), 63 in Orthopedics (7.0%) and 55 in Endocrinology departments (6.1%), and the difference in the positive rate among different departments were also statistically significant (χ(2) = 271.585, P < 0.05). Among the 480 cases who were followed-up, 215 (44.79%) were lost to follow-up, 84 cases (39.07%) were unregistered, 77 cases (16.04%) were untreated, 15 cases (19.48%) were unaware of their state of illness, 46 cases (59.74%) were diagnosed without concern, 16 cases (20.78%) were diagnosed but did not take medicine, 60 cases were under treatment, and 29 cases were mostly on counterfeit drugs (48.33%). Conclusion: Comprehensive diagnosis and treatment education to non-specialist clinicians and timely manner regular follow-up of patients is a key factor and an important link to formulate a simple, easy and sustainable model to improve the efficiency of screening, diagnosis, and treatment of hepatitis C micro-elimination strategy in hospital. In addition, it will also play an important role in achieving the strategic goal of "eliminating hepatitis C as a public health threat by 2030".
Collapse
Affiliation(s)
- N He
- Department of Gastroenteology, The First Affiliated Hospital of Xi 'an Medical University, Xi 'an 710006, China
| | - S Hao
- Xi 'an Medical University, Xi 'an 710077, China
| | - G Feng
- Institute of General Practice, Xi 'an Medical University, Xi 'an 710077, China
| | - J Gao
- Clinical Laboratory, The First Affiliated Hospital of Xi 'an Medical University, Xi 'an 710006, China
| | - F J Kong
- Xi 'an Medical University, Xi 'an 710077, China
| | - Z X Ren
- Xi 'an Medical University, Xi 'an 710077, China
| | - M Q Xu
- Xi 'an Medical University, Xi 'an 710077, China
| | - Y Q Yang
- Department of Gastroenteology, The First Affiliated Hospital of Xi 'an Medical University, Xi 'an 710006, China
| |
Collapse
|
5
|
Fan-Zhen M, Xiang-Zhen X, Xiao-Lin J, Bi-Xian N, Yang D. [Current status of chronic filariasis in Jiangsu Province]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2018; 30:563-566. [PMID: 30567033 DOI: 10.16250/j.32.1374.2018215] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
OBJECTIVE To understand the current status of chronic filariasis patients in Jiangsu Province so as to provide basic data for following-up care for them. METHODS The patients were followed up one by one according to history archives between June and July, 2018, and the clue investigation was also conducted. The base data of the patients was collected through a face-to-face questionnaire survey and analyzed. RESULTS There were still 3 160 chronic filariasis patients in Jiangsu Province. Among them, the male accounted for 40.0%, and 91.8% of the patients were older adults aged 60 years or above. From the aspect of regional distribution, Suqian (24.2%), Huai'an (19.5%), Suzhou (17.3%), Xuzhou (11.2%), and Yancheng (9.8%) were the five top high prefectures. The patients with simple lymphatic inflammation or lymphadenitis, simple lymphedema or elephantiasis, simple chyluria, simple hydrocele of tunica vaginalis, and two symptoms or more accounted for 2.7%, 37.1%, 11.2%, 0.9%, and 48.1%, respectively. For the patients with lymphedema or elephantiasis, 97.8% of edema was seen in the lower limbs, and more than 90% of the edema stages were I-III. The number of current caring sites was 220, covering 2 091 patients. The average number of times of caring activities in this year was 3.2. The average cumulative time of caring activities among all the sites was 11.3 years. CONCLUSIONS The number of chronic filariasis patients has been dramatically decreased, most of the patients are old and have long disease durations. The caring sites have not covered all the patients. In order to release the symptoms and improve the life quality of the patients, all the patients should be taken care of in Jiangsu Province.
Collapse
Affiliation(s)
- Mao Fan-Zhen
- Key Laboratory of National Health Commission on Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi 214064, China
| | - Xu Xiang-Zhen
- Key Laboratory of National Health Commission on Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi 214064, China
| | - Jin Xiao-Lin
- Key Laboratory of National Health Commission on Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi 214064, China
| | - Ni Bi-Xian
- Key Laboratory of National Health Commission on Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi 214064, China
| | - Dai Yang
- Key Laboratory of National Health Commission on Parasitic Disease Control and Prevention, Jiangsu Provincial Key Laboratory on Parasite and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi 214064, China
| |
Collapse
|
6
|
Zhi-Hua Z, Qing Y, Tian T, Wei-Ping W, Ning X. [Evaluation on application of China Disease Prevention and Control Information System of Hydatid Disease Ⅰ Current status at the provincial level]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2018; 28:244-246. [PMID: 29469413 DOI: 10.16250/j.32.1374.2015190] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
OBJECTIVE To evaluate the application status of China Disease Prevention and Control Information System of Hydatid Disease, in which questions existed are summarized in order to promote the system update. METHODS A questionnaire was designed and distributed to Inner Mongolia, Sichuan, Tibet, Gansu, Qinghai, Ningxia, Xinjiang and Xinjiang Production and Construction Corps to evaluate the application status of China Disease Prevention and Control Information System of Hydatid Disease assistant with telephone. RESULTS The recovery rate of questionnaires was 87.5%. The statistics of closed questions showed that national application rate of the China Disease Prevention and Control Information System of Hydatid Disease was 100%, of which 15.3% were low frequency users, 57.1% believed the system was necessary, 28.6% considered it was dispensable, and 14.3% believed that it was totally unnecessary. The statistics of open-ended questions indicated that 6 endemic regions suggested to increase the guidance and training, while 4 endemic regions had opinions on sharing the information of the national infectious disease reporting systems and hydatid disease prevention and control information system, and the opinions on turning monthly report to quarterly report, and increasing statistics and analysis module, and 3 endemic regions deemed that the system had logic errors and defects. CONCLUSIONS The problems of the system are mainly focused on the existence of systemic deficiencies and logic errors, lacking of statistical parameters and corresponding analysis function module, and lacking of the guidance and training, which limits the use of the system. Therefore, these problems should be resolved.
Collapse
Affiliation(s)
- Zhang Zhi-Hua
- National Institute of Parasitic Diseases, China CDC, Key Laboratory of Parasite and Vector Biology, National health and Family Planning Commission, WHO Collaborating Center for Tropical Diseases, Shanghai 200025, China
| | - Yu Qing
- National Institute of Parasitic Diseases, China CDC, Key Laboratory of Parasite and Vector Biology, National health and Family Planning Commission, WHO Collaborating Center for Tropical Diseases, Shanghai 200025, China
| | - Tian Tian
- National Institute of Parasitic Diseases, China CDC, Key Laboratory of Parasite and Vector Biology, National health and Family Planning Commission, WHO Collaborating Center for Tropical Diseases, Shanghai 200025, China
| | - Wu Wei-Ping
- National Institute of Parasitic Diseases, China CDC, Key Laboratory of Parasite and Vector Biology, National health and Family Planning Commission, WHO Collaborating Center for Tropical Diseases, Shanghai 200025, China
| | - Xiao Ning
- National Institute of Parasitic Diseases, China CDC, Key Laboratory of Parasite and Vector Biology, National health and Family Planning Commission, WHO Collaborating Center for Tropical Diseases, Shanghai 200025, China
| |
Collapse
|